Address: 1st Tverskaya-Yamskaya st., 21 Business Centre ‘Four Winds Plaza’ 125047, Moscow,Russia
Tel: +7 495 777 6 555
Committed to Improving the Lives of Patients Worldwide
Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin’s lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.
As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.
Celgene in Russia
Celgene Russia was established as an entity in 2008. It actively engages in Russian clinical trials, and marketing and product promotion. It aims to establish market leadership in indications that are in line with Celgene’s global strategy, as well as develop a strong presence in state reimburesement programs.
Products and services
Drug therapies for cancer and inflammatory disorders.